Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) [Phase 1]

View source ↗

Summary

The document provides a Phase 1 update on safety, tolerability, and pharmacokinetics of bimatoprost in men with androgenetic alopecia. The study has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Alopecia, Alopecia, Androgenetic | Phase 1 | Status: TERMINATED